We need more specific therapies because current approaches result in many side-effects. That's why we invented CATE, the first all-in-one
living cancer therapeutic with an integrated two-step safety mechanism. That's why we created CATE: Cancer-Targeting E. coli.
A living cure to a living disease.
Background
It features two safety checkpoint mechanisms to ensure only tumor cells are damaged.
Description
Treatment